PAVM News and Press, PAVmed Inc. From 05/07/24

Lucid Diagnostics Closes Series B / B-1 Preferred Stock Offering and Appoints Healthcare Industry Veteran Dennis Matheis to Board of Directors PR Newswire Final closing yields total gross proceeds of $29.8 million from offering Mr. Matheis serves as President ...

PAVmed to Hold a Business Update Conference Call and Webcast on May 14, 2024 PR Newswire Conference Call and Webcast at 8:30 AM Eastern Time NEW YORK , May 3, 2024 /PRNewswire/ -- PAVmed Inc. (Nasdaq: PAVM, PAVMZ ) ("PAVmed" or the "Compan...

Lucid Diagnostics to Hold a Business Update Conference Call and Webcast on May 13, 2024 PR Newswire Conference Call and Webcast at 8:30AM Eastern Time NEW YORK , May 2, 2024 /PRNewswire/ -- Lucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid" or...

Lucid Diagnostics Announces Peer-Reviewed Publication of Positive Data from National Cancer Institute-Sponsored, Prospective, Multicenter Clinical Validation Study of EsoGuard® Esophageal Precancer Testing PR Newswire EsoGuard demonstrated unprecedented early precancer de...

PAVmed Subsidiary, Veris Health, Signs Memorandum of Understanding with The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute PR Newswire Parties to implement a pilot program of the Veris Cancer Care Platform NEW ...

Lucid Diagnostics Partners with the Esophageal Cancer Action Network (ECAN) to Highlight Esophageal Cancer Awareness Month PR Newswire NEW YORK , April 29, 2024 /PRNewswire/ -- Lucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid" or the "Company") a commer...

Lucid Diagnostics to Participate in Fireside Chat at the 23rd Annual Needham Virtual Healthcare Conference PR Newswire NEW YORK , April 8, 2024 /PRNewswire/ -- Lucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid" or the "Company") a commercial-stage, cancer prevention...

2024-03-28 10:01:50 ET More on Health Care Select Sector SPDR XLV: Fundamentals Don't Support Overweighting Health Care XLV: Low-Cost Exposure To A Defensive Sector, While Achieving Strong Performance Healthcare In 2024: Navigating The Biopharma Bull Run John...

2024-03-27 15:12:10 ET PAVmed Inc. (PAVM) Q4 2023 Earnings Conference Call March 27, 2024 08:30 ET Company Participants Dennis McGrath - Executive Vice President & Chief Financial Officer Lishan Aklog - Chairman & Chief Executive Officer Conference Call...

2024-03-27 00:53:53 ET More on PAVmed Seeking Alpha’s Quant Rating on PAVmed Historical earnings data for PAVmed Financial information for PAVmed Read the full article on Seeking Alpha For further details see: PAVmed Non-GAAP EPS of -$1.33 ...